CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2562.0010.35 (+0.41 %)
PREV CLOSE () 2551.65
OPEN PRICE () 2506.50
BID PRICE (QTY) 2563.30 (1)
OFFER PRICE (QTY) 2566.95 (9)
VOLUME 4556
TODAY'S LOW / HIGH ()2506.50 2593.15
52 WK LOW / HIGH ()1910.1 3050
NSE2557.30-0.2 (-0.01 %)
PREV CLOSE() 2557.50
OPEN PRICE () 2537.50
BID PRICE (QTY) 2555.60 (1)
OFFER PRICE (QTY) 2557.40 (6)
VOLUME 94610
TODAY'S LOW / HIGH() 2520.00 2595.00
52 WK LOW / HIGH ()1901.05 3054.8
ChairmanRamesh Juneja
Managing DirectorRajeev Juneja
Company SecretaryHitesh Kumar Jain
Non Executive Independent DirectorT P Ostwal
Vijaya Sampath
Bharat Anand
Vivek Kalra
Whole Time DirectorSheetal Arora
Satish Kumar Sharma
Incorporation Year : 03-07 1991

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111 New Delhi,
Delhi-110020 .

Phone : 011-46846700

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX80212.591000.06 (1.26%)
NIFTY24311.80272.45 (1.13%)
Dow Jones 40113.5020.10 (0.05%)
Nasdaq 17382.94216.90 (1.26%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI